Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Ophthalmology. 2021 Apr 20;128(12):1699–1707. doi: 10.1016/j.ophtha.2021.04.017

Figure 1.

Figure 1.

Flow diagram of inclusion and exclusion criteria for study cohort

OLDW = OptumLabs Data Warehouse; ICD = International Classification of Disease; HZ = Herpes zoster; HZO = Herpes Zoster Ophthalmicus; RZV = Recombinant Zoster Vaccine

a Index date was defined as the date at which an individual was eligible for study inclusion.

b Two valid doses of recombinant zoster vaccine were defined as receiving the second dose between 30 and 210 days after the first dose.